Rukobia is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Fostemsavir Tromethamine.
| Product ID | 49702-250_3710c1a6-34c5-423d-8f79-3c98506ebcb6 |
| NDC | 49702-250 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rukobia |
| Generic Name | Fostemsavir Tromethamine |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-07-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212950 |
| Labeler Name | ViiV Healthcare Company |
| Substance Name | FOSTEMSAVIR TROMETHAMINE |
| Active Ingredient Strength | 600 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2020-07-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RUKOBIA 86825499 5117272 Live/Registered |
Glaxo Group Limited 2015-11-19 |